Skip to content
Disclosery

EXANE DERIVATIVES: CHTR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CHTR, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 185 CHTR shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 185 shares
    Change vs previous 13F -5 shares

    0.05% of the 13F portfolio, value $86,664.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 190 shares
    Change vs previous 13F -566 shares

    0.03% of the 13F portfolio, value $103,646.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 756 shares
    Change vs previous 13F +32 shares

    0.12% of the 13F portfolio, value $492,887.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 724 shares
    Change vs previous 13F +485 shares

    0.13% of the 13F portfolio, value $526,751.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 239 shares
    Change vs previous 13F -17 shares

    0.04% of the 13F portfolio, value $169,857.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 256 shares
    Change vs previous 13F -1,985 shares

    0.05% of the 13F portfolio, value $157,956.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 2,241 shares
    Change vs previous 13F -129 shares

    0.45% of the 13F portfolio, value $1,482,521.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 2,370 shares
    Change vs previous 13F not available

    0.48% of the 13F portfolio, value $1,479,651.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).